Wedbush Securities’s Aquestive Therapeutics AQST Stock Holding History

Wedbush Securities’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60K	Buy	+14,500	New	+$61K	﹤0.01%	1285
2021 Q3	–	Sell	-10,500	Closed	-$42K	–	1171
2021 Q2	$42K	Buy	10,500 +500	+5%	+$2K	﹤0.01%	1150
2021 Q1	$52K	Buy	+10,000	New	+$53.2K	﹤0.01%	1063
2020 Q4	–	Sell	-103,240	Closed	-$501K	–	873
2020 Q3	$501K	Sell	103,240 -33,683	-25%	-$220K	0.05%	429
2020 Q2	$665K	Buy	136,923 +50,157	+58%	+$231K	0.06%	322
2020 Q1	$190K	Buy	86,766 +24,332	+39%	+$92.4K	0.02%	700
2019 Q4	$363K	Sell	62,434 -36,055	-37%	-$188K	0.03%	595
2019 Q3	$313K	Buy	98,489 +27,756	+39%	+$104K	0.03%	621
2019 Q2	$297K	Buy	+70,733	New	+$362K	0.03%	631

Other funds holding AQST

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

SWRP

Summit Wealth & Retirement Planning San Ramon, California $472M AUM 25.49% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

ACA

Adirondack Capital Advisors Syracuse, New York $186M AUM

Wedbush Securities's AQST Position: Q2 2026 in Review

Wedbush Securities opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 14,500 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #1285 among its holdings. This is a return to the name: Wedbush Securities previously reported a position in AQST as recently as Q2 2021.

Wedbush Securities first reported a position in AQST in Q2 2019 and has held it in 9 quarters since. The position peaked at $665K in Q2 2020. 28 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

Wedbush Securities held 14,500 shares of Aquestive Therapeutics worth $60K as of Q2 2026.
Aquestive Therapeutics was a new Wedbush Securities position in Q2 2026.
Aquestive Therapeutics made up ﹤0.01% of Wedbush Securities's portfolio in Q2 2026, its #1285 holding.
Wedbush Securities first reported a position in Aquestive Therapeutics in Q2 2019 and has held it in 9 quarters since.
Wedbush Securities's Aquestive Therapeutics position peaked at $665K in Q2 2020.
28 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.